Eikelboom JW - Search Results

1

Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy.

Eikelboom JW, Mehta SR, Pogue J, Yusuf S. Eikelboom JW, et al. JAMA. 2001 Jan 24-31;285(4):444-50. doi: 10.1001/jama.285.4.444. JAMA. 2001. PMID: 11242429

2

Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis.

Mehta SR, Eikelboom JW, Yusuf S. Mehta SR, et al. Among authors: eikelboom jw. Lancet. 2000 Aug 5;356(9228):449-54. doi: 10.1016/S0140-6736(00)02552-6. Lancet. 2000. PMID: 10981887

3

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Eikelboom JW, et al. Lancet. 2000 Jun 3;355(9219):1936-42. doi: 10.1016/S0140-6736(00)02324-2. Lancet. 2000. PMID: 10859038

4

Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.

Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, Yusuf S. Mehta SR, et al. Among authors: eikelboom jw. J Am Coll Cardiol. 2001 Jan;37(1):37-43. doi: 10.1016/s0735-1097(00)01089-5. J Am Coll Cardiol. 2001. PMID: 11153770 Free article. Clinical Trial.

5

Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study.

Eikelboom JW, Anand SS, Mehta SR, Weitz JI, Yi C, Yusuf S. Eikelboom JW, et al. Circulation. 2001 Feb 6;103(5):643-50. doi: 10.1161/01.cir.103.5.643. Circulation. 2001. PMID: 11156874 Clinical Trial.

6

Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.

Mehta SR, Eikelboom JW, Rupprecht HJ, Lewis BS, Natarajan MK, Yi C, Pogue J, Yusuf S. Mehta SR, et al. Among authors: eikelboom jw. Eur Heart J. 2002 Jan;23(2):117-23. doi: 10.1053/euhj.2001.2731. Eur Heart J. 2002. PMID: 11785993 Clinical Trial.

7

Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial.

Anderson JA, Hirsh J, Yusuf S, Johnston M, Afzal R, Mehta SR, Fox KA, Budaj A, Eikelboom JW. Anderson JA, et al. Among authors: eikelboom jw. J Thromb Haemost. 2010 Feb;8(2):243-9. doi: 10.1111/j.1538-7836.2009.03705.x. Epub 2009 Nov 26. J Thromb Haemost. 2010. PMID: 19943881 Free article. Clinical Trial.

8

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Eikelboom JW, et al. Ann Intern Med. 1999 Sep 7;131(5):363-75. doi: 10.7326/0003-4819-131-5-199909070-00008. Ann Intern Med. 1999. PMID: 10475890 Review.

9

Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?

Fox KAA, Eikelboom JW, Anand SS, Bhatt DL, Bosch J, Connolly SJ, Harrington RA, Steg PG, Yusuf S. Fox KAA, et al. Among authors: eikelboom jw. Eur Heart J. 2019 May 7;40(18):1466-1471. doi: 10.1093/eurheartj/ehy347. Eur Heart J. 2019. PMID: 29945212 No abstract available.

10

Aspirin resistance and its implications in clinical practice.

Eikelboom J, Feldman M, Mehta SR, Michelson AD, Oates JA, Topol E. Eikelboom J, et al. MedGenMed. 2005 Jul 11;7(3):76. MedGenMed. 2005. PMID: 16369302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

603 results

Search Page

Filters